Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).
Brito D, Albrecht FC, de Arenaza DP, Bart N, Better N, Carvajal-Juarez I, Conceição I, Damy T, Dorbala S, Fidalgo JC, Garcia-Pavia P, Ge J, Gillmore JD, Grzybowski J, Obici L, Piñero D, Rapezzi C, Ueda M, Pinto FJ. Brito D, et al. Among authors: rapezzi c. Glob Heart. 2023 Oct 26;18(1):59. doi: 10.5334/gh.1262. eCollection 2023. Glob Heart. 2023. PMID: 37901600 Free PMC article. Review.
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
Gonzalez-Lopez E, Escobar-Lopez L, Obici L, Saturi G, Bezard M, Saith SE, AbouEzzeddine OF, Mussinelli R, Gagliardi C, Kharoubi M, Griffin JM, Dispenzieri A, Vilches S, Perlini S, Longhi S, Oghina S, Rivas A, Grogan M, Maurer MS, Damy T, Palladini G, Rapezzi C, Garcia-Pavia P. Gonzalez-Lopez E, et al. Among authors: rapezzi c. JACC CardioOncol. 2022 Nov 15;4(4):442-454. doi: 10.1016/j.jaccao.2022.07.007. eCollection 2022 Nov. JACC CardioOncol. 2022. PMID: 36444226 Free PMC article.
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis.
Aimo A, Tomasoni D, Porcari A, Vergaro G, Castiglione V, Passino C, Adamo M, Bellicini MG, Lombardi CM, Nardi M, Palamara G, Varrà GG, Saro R, Allegro V, Merlo M, Sinagra G, Metra M, Emdin M, Rapezzi C. Aimo A, et al. Among authors: rapezzi c. Eur J Heart Fail. 2023 Apr;25(4):510-514. doi: 10.1002/ejhf.2824. Epub 2023 Mar 15. Eur J Heart Fail. 2023. PMID: 36919654 Free article.
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis.
Rauf MU, Hawkins PN, Cappelli F, Perfetto F, Zampieri M, Argiro A, Petrie A, Law S, Porcari A, Razvi Y, Bomsztyk J, Ravichandran S, Ioannou A, Patel R, Starr N, Hutt DF, Mahmood S, Wisniowski B, Martinez-Naharro A, Venneri L, Whelan C, Roczenio D, Gilbertson J, Lachmann HJ, Wechalekar AD, Rapezzi C, Serenelli M, Massa P, Caponetti AG, Ponziani A, Accietto A, Giovannetti A, Saturi G, Sguazzotti M, Gagliardi C, Biagini E, Longhi S, Fontana M, Gillmore JD. Rauf MU, et al. Among authors: rapezzi c. Eur Heart J. 2023 Jun 25;44(24):2187-2198. doi: 10.1093/eurheartj/ehad139. Eur Heart J. 2023. PMID: 36946431 Free PMC article.
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology.
Moura B, Aimo A, Al-Mohammad A, Keramida K, Ben Gal T, Dorbala S, Todiere G, Cameli M, Barison A, Bayes-Genis A, von Bardeleben RS, Bucciarelli-Ducci C, Delgado V, Mordi IR, Seferovic P, Savarese G, Čelutkienė J, Rapezzi C, Emdin M, Coats A, Metra M, Rosano G. Moura B, et al. Among authors: rapezzi c. Eur J Heart Fail. 2023 Sep;25(9):1493-1506. doi: 10.1002/ejhf.2997. Epub 2023 Sep 4. Eur J Heart Fail. 2023. PMID: 37581253
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study.
Aimo A, Teresi L, Castiglione V, Picerni AL, Niccolai M, Severino S, Agazio A, Carnevale Baraglia A, Obici L, Palladini G, Ponti L, Argirò A, Cappelli F, Perfetto F, Serenelli M, Trimarchi G, Licordari R, Di Bella G, Chubuchna O, Quattrone F, Nuti S, De Rosis S, Passino C, Rapezzi C, Merlini G, Emdin M, Vergaro G. Aimo A, et al. Among authors: rapezzi c. Amyloid. 2024 Mar;31(1):52-61. doi: 10.1080/13506129.2023.2254451. Epub 2023 Sep 5. Amyloid. 2024. PMID: 37668548
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, Hung RR, Gottlieb RL, Damy T, González-Duarte A, Sarswat N, Sekijima Y, Tahara N, Taylor MS, Kubanek M, Donal E, Palecek T, Tsujita K, Tang WHW, Yu WC, Obici L, Simões M, Fernandes F, Poulsen SH, Diemberger I, Perfetto F, Solomon SD, Di Carli M, Badri P, White MT, Chen J, Yureneva E, Sweetser MT, Jay PY, Garg PP, Vest J, Gillmore JD; APOLLO-B Trial Investigators. Maurer MS, et al. N Engl J Med. 2023 Oct 26;389(17):1553-1565. doi: 10.1056/NEJMoa2300757. N Engl J Med. 2023. PMID: 37888916 Free PMC article. Clinical Trial.
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy.
Porcari A, Fontana M, Canepa M, Biagini E, Cappelli F, Gagliardi C, Longhi S, Pagura L, Tini G, Dore F, Bonfiglioli R, Bauckneht M, Miceli A, Girardi F, Martini AL, Barbati G, Costanzo EN, Caponetti AG, Paccagnella A, Sguazzotti M, La Malfa G, Zampieri M, Sciagrà R, Perfetto F, Rowczenio D, Gilbertson J, Hutt DF, Hawkins PN, Rapezzi C, Merlo M, Sinagra G, Gillmore JD. Porcari A, et al. Among authors: rapezzi c. Circulation. 2024 Apr 9;149(15):1157-1168. doi: 10.1161/CIRCULATIONAHA.123.066524. Epub 2024 Feb 8. Circulation. 2024. PMID: 38328945 Free PMC article.
The treatment of amyloidosis is being refined.
Cantone A, Sanguettoli F, Dal Passo B, Serenelli M, Rapezzi C. Cantone A, et al. Among authors: rapezzi c. Eur Heart J Suppl. 2022 Nov 12;24(Suppl I):I131-I138. doi: 10.1093/eurheartjsupp/suac104. eCollection 2022 Nov. Eur Heart J Suppl. 2022. PMID: 36380794 Free PMC article.
499 results